nipecotic acid has been researched along with nnc 05-2090 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Egebjerg, J; Sørensen, PO; Thomsen, C | 1 |
Arisawa, M; Hayakawa, W; Ide, S; Ito, Y; Katayama, T; Kawamura, S; Kobayashi, T; Masuda, E; Minami, M; Nakada, K; Shuto, S; Suemasa, A; Yamada, S; Yoshikawa, M | 1 |
2 other study(ies) available for nipecotic acid and nnc 05-2090
Article | Year |
---|---|
1-(3-(9H-carbazol-9-yl)-1-propyl)-4-(2-methoxyphenyl)-4-piperidinol, a novel subtype selective inhibitor of the mouse type II GABA-transporter.
Topics: Animals; Carrier Proteins; Cell Line; Cricetinae; GABA Plasma Membrane Transport Proteins; gamma-Aminobutyric Acid; Membrane Proteins; Membrane Transport Proteins; Mice; Neurotransmitter Uptake Inhibitors; Nipecotic Acids; Organic Anion Transporters; Piperidines; Proline; Tiagabine | 1997 |
Cyclopropane-based conformational restriction of GABA by a stereochemical diversity-oriented strategy: identification of an efficient lead for potent inhibitors of GABA transports.
Topics: Animals; Anticonvulsants; Brain; Cyclopropanes; GABA Modulators; GABA Plasma Membrane Transport Proteins; gamma-Aminobutyric Acid; Ligands; Mice; Protein Binding; Rats; Seizures; Stereoisomerism; Structure-Activity Relationship | 2013 |